StockDuty ← Dashboard Nov 04, 2026 10:13 PM ET
SignalCorporate

Nuvation Bio GAAP EPS of -$0.12 in-line, revenue of $45M beats by $10.58M

Revenue beat by $10.58M while GAAP EPS met expectations at -$0.12.

What changed
Revenue beat by $10.58M while GAAP EPS met expectations at -$0.12.
Why it matters
Revenue beat by $10.58M while GAAP EPS met expectations at -$0.12. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →